دورية أكاديمية
CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway
| العنوان: | CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway |
|---|---|
| المؤلفون: | Jiang, Fei, Wang, Meng-qing, Zhang, Man-yu, Gu, Sheng-long, Xie, Ya-wen, Huang, Yan, Zhou, Meng-yuan, Li, Fei-long, Yang, Yu-chen, Zhang, Pei-pei, Liu, Xue-song, Li, Rong |
| المصدر: | In International Immunopharmacology 20 April 2024 131 |
| قاعدة البيانات: | ScienceDirect |
Full Text Finder | تدمد: | 15675769 |
|---|---|
| DOI: | 10.1016/j.intimp.2024.111850 |